DrugPatentWatch Database Preview
Details for Patent: 8,530,509
» See Plans and Pricing
Which drugs does patent 8,530,509 protect, and when does it expire?
Patent 8,530,509 protects TPOXX and is included in one NDA.
This patent has thirty-one patent family members in eleven countries.
Summary for Patent: 8,530,509
| Title: | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| Abstract: | Methods of using di, tri, and tetracyclic acylhydrazide derivatives and analogs, as well as pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases caused by the orthopoxvirus. |
| Inventor(s): | Jordan; Robert (Corvallis, OR), Bailey; Thomas R. (Phoenixville, PA), Rippin; Susan R. (Wilmington, DE), Dai; Dongcheng (Corvallis, OR) |
| Assignee: | Siga Technologies, Inc. (Corvallis, OR) |
| Application Number: | 13/194,437 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 8,530,509
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Siga Technologies | TPOXX | tecovirimat | CAPSULE;ORAL | 208627-001 | Jul 13, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,530,509
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2004249250 | Start Trial | |||
| Australia | 2007351866 | Start Trial | |||
| Canada | 2529761 | Start Trial | |||
| Canada | 2685153 | Start Trial | |||
| Canada | 2685198 | Start Trial | |||
| Canada | 2866037 | Start Trial | |||
| Canada | 2966466 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
